| (+)-alpha-tocopherol | increases expression | ISO | RGD:2679 | 6480464 | alpha-Tocopherol results in increased expression of GFAP protein | CTD | PMID:18942769 |
| (R)-lipoic acid | decreases expression | EXP | | 6480464 | Thioctic Acid results in decreased expression of GFAP mRNA | CTD | PMID:19555370 |
| (S)-amphetamine | increases expression | EXP | | 6480464 | Dextroamphetamine results in increased expression of GFAP protein | CTD | PMID:15337264 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of GFAP mRNA | CTD | PMID:17997037 |
| (S)-nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of GFAP mRNA | CTD | PMID:21955143 |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | decreases expression | ISO | RGD:619574 | 6480464 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased expression of GFAP mRNA | CTD | PMID:16580782 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | EXP | | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein | CTD | PMID:19199078 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | zonisamide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] | CTD | PMID:19199078 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | Dieldrin promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] | CTD | PMID:16809432 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of GFAP mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GFAP mRNA; more ... | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GFAP mRNA; more ... | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2679 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GFAP mRNA | CTD | PMID:19490992 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GFAP mRNA | CTD | PMID:18343893 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GFAP protein | CTD | PMID:15337264 |
| 3,4-methylenedioxymethamphetamine | multiple interactions | EXP | | 6480464 | Caffeine promotes the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GFAP protein] | CTD | PMID:19882200 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GFAP protein | CTD | PMID:15337264 PMID:19882200 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:2679 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GFAP protein | CTD | PMID:16489401 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of GFAP protein | CTD | PMID:21296659 |
| 6-propyl-2-thiouracil | increases expression | ISO | RGD:2679 | 6480464 | Propylthiouracil results in increased expression of GFAP protein | CTD | PMID:22504374 |
| 6alpha-methylprednisolone | decreases expression | ISO | RGD:619574 | 6480464 | Methylprednisolone results in decreased expression of GFAP protein | CTD | PMID:18509235 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:2679 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GFAP mRNA | CTD | PMID:15994020 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:2679 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA] | CTD | PMID:15994020 |
| acetic acid | decreases expression | EXP | | 6480464 | Acetic Acid results in decreased expression of GFAP protein | CTD | PMID:21296659 |
| acetylsalicylic acid | decreases expression | ISO | RGD:619574 | 6480464 | Aspirin results in decreased expression of GFAP protein; more ... | CTD | PMID:16516312 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of GFAP mRNA | CTD | PMID:21353610 |
| acrylamide | increases expression | ISO | RGD:619574 | 6480464 | Acrylamide results in increased expression of GFAP protein | CTD | PMID:19426797 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:619574 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in increased expression of GFAP protein | CTD | PMID:18098270 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of GFAP mRNA; more ... | CTD | PMID:11311979 |
| all-trans-retinoic acid | increases expression | ISO | RGD:619574 | 6480464 | Tretinoin results in increased expression of GFAP protein | CTD | PMID:17960384 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:619574 | 6480464 | Tretinoin results in increased expression of GFAP protein | CTD | PMID:18098270 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:619574 | 6480464 | Tretinoin results in increased expression of GFAP protein | CTD | PMID:18098270 more ... |
| all-trans-retinoic acid | decreases expression | ISO | RGD:2679 | 6480464 | Tretinoin results in decreased expression of GFAP protein | CTD | PMID:16944780 |
| all-trans-retinoic acid | increases expression | ISO | RGD:619574 | 6480464 | Tretinoin results in increased expression of GFAP protein | CTD | PMID:17960384 more ... |
| aluminium atom | increases expression | ISO | RGD:2679 | 6480464 | Aluminum results in increased expression of GFAP protein | CTD | PMID:16545059 |
| aluminium atom | multiple interactions | ISO | RGD:2679 | 6480464 | Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] | CTD | PMID:16545059 |
| aluminium trichloride | decreases expression | ISO | RGD:619574 | 6480464 | aluminum chloride results in decreased expression of GFAP mRNA | CTD | PMID:9826787 |
| aluminium(0) | increases expression | ISO | RGD:2679 | 6480464 | Aluminum results in increased expression of GFAP protein | CTD | PMID:16545059 |
| aluminium(0) | multiple interactions | ISO | RGD:2679 | 6480464 | Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] | CTD | PMID:16545059 |
| aminoguanidine | multiple interactions | ISO | RGD:2679 | 6480464 | pimagedine inhibits the reaction [Capsaicin results in increased expression of GFAP protein]; more ... | CTD | PMID:20826152 |
| ammonia | multiple interactions | ISO | RGD:619574 | 6480464 | IL1B protein promotes the reaction [Ammonia results in decreased expression of GFAP mRNA] | CTD | PMID:20217200 |
| ammonia | decreases expression | ISO | RGD:619574 | 6480464 | Ammonia results in decreased expression of GFAP mRNA | CTD | PMID:20217200 |
| ammonium chloride | decreases expression | ISO | RGD:2679 | 6480464 | Ammonium Chloride results in decreased expression of GFAP mRNA; more ... | CTD | PMID:16483693 |
| amphetamine | increases expression | ISO | RGD:619574 | 6480464 | Amphetamine results in increased expression of GFAP protein | CTD | PMID:15814102 |
| amphetamine | increases expression | ISO | RGD:2679 | 6480464 | Amphetamine results in increased expression of GFAP mRNA | CTD | PMID:15183010 PMID:20223277 |
| amphetamine | increases expression | ISO | RGD:2679 | 6480464 | Amphetamine results in increased expression of GFAP protein | CTD | PMID:15183010 |
| amphetamine | increases expression | ISO | RGD:2679 | 6480464 | Amphetamine results in increased expression of GFAP mRNA | CTD | PMID:20223277 PMID:15183010 |
| astaxanthin | decreases expression | EXP | | 6480464 | astaxanthine results in decreased expression of GFAP mRNA | CTD | PMID:19555370 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of GFAP mRNA | CTD | PMID:20127859 |
| benzo[a]pyrene | decreases expression | ISO | RGD:619574 | 6480464 | Benzo(a)pyrene results in decreased expression of GFAP mRNA | CTD | PMID:22316170 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GFAP protein | CTD | PMID:16684133 more ... |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GFAP protein | CTD | PMID:17210262 more ... |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GFAP protein | CTD | PMID:16860915 more ... |
| bisphenol A | multiple interactions | EXP | | 6480464 | Tamoxifen inhibits the reaction [bisphenol A results in increased expression of GFAP protein] | CTD | PMID:16860915 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GFAP protein | CTD | PMID:16860915 more ... |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GFAP protein | CTD | PMID:17210262 more ... |
| bromochloroacetic acid | decreases expression | EXP | | 6480464 | bromochloroacetic acid results in decreased expression of GFAP protein | CTD | PMID:21296659 |
| cadmium dichloride | decreases expression | ISO | RGD:2679 | 6480464 | Cadmium Chloride results in decreased expression of GFAP protein | CTD | PMID:20829427 |
| cadmium dichloride | multiple interactions | ISO | RGD:2679 | 6480464 | [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in decreased expression of GFAP protein | CTD | PMID:20829427 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine promotes the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GFAP protein] | CTD | PMID:19882200 |
| calcitriol | affects expression | EXP | | 6480464 | Calcitriol affects the expression of GFAP mRNA | CTD | PMID:15138306 |
| calcium atom | multiple interactions | ISO | RGD:2679 | 6480464 | Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] | CTD | PMID:21879721 |
| calcium atom | multiple interactions | ISO | RGD:2679 | 6480464 | Calcium deficiency inhibits the reaction [Ethanol results in increased expression of GFAP protein] | CTD | PMID:17888892 |
| calcium(0) | multiple interactions | ISO | RGD:2679 | 6480464 | Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] | CTD | PMID:21879721 |
| calcium(0) | multiple interactions | ISO | RGD:2679 | 6480464 | Calcium deficiency inhibits the reaction [Ethanol results in increased expression of GFAP protein] | CTD | PMID:17888892 |
| capsaicin | increases expression | ISO | RGD:619574 | 6480464 | Capsaicin results in increased expression of GFAP mRNA | CTD | PMID:18405923 |
| capsaicin | increases expression | ISO | RGD:2679 | 6480464 | Capsaicin results in increased expression of GFAP protein | CTD | PMID:20826152 |
| capsaicin | multiple interactions | ISO | RGD:2679 | 6480464 | [7-nitroindazole co-treated with pimagedine] promotes the reaction [Capsaicin results in increased expression of GFAP protein]; more ... | CTD | PMID:20826152 |
| capsaicin | multiple interactions | ISO | RGD:2679 | 6480464 | Capsaicin inhibits the reaction [IL6 protein results in increased expression of GFAP mRNA] | CTD | PMID:19285962 |
| carbofuran | decreases expression | ISO | RGD:2679 | 6480464 | Carbofuran results in decreased expression of GFAP protein | CTD | PMID:22240977 |
| carbonyl sulfide | affects expression | ISO | RGD:2679 | 6480464 | carbonyl sulfide affects the expression of GFAP mRNA | CTD | PMID:19395590 |
| carmustine | multiple interactions | ISO | RGD:2679 | 6480464 | Melatonin inhibits the reaction [Carmustine results in decreased expression of GFAP protein] | CTD | PMID:17572393 |
| carmustine | decreases expression | ISO | RGD:2679 | 6480464 | Carmustine results in decreased expression of GFAP protein | CTD | PMID:17572393 |
| carmustine | decreases expression | ISO | RGD:619574 | 6480464 | Carmustine results in decreased expression of GFAP mRNA | CTD | PMID:15980968 |
| chlorpyrifos | decreases expression | ISO | RGD:2679 | 6480464 | Chlorpyrifos results in decreased expression of GFAP mRNA | CTD | PMID:17452286 |
| chlorpyrifos | increases expression | ISO | RGD:2679 | 6480464 | Chlorpyrifos results in increased expression of GFAP mRNA | CTD | PMID:16675515 |
| chlorpyrifos | decreases expression | ISO | RGD:2679 | 6480464 | Chlorpyrifos results in decreased expression of GFAP mRNA | CTD | PMID:17452286 PMID:20691718 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene | CTD | PMID:20938992 |
| clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA; more ... | CTD | PMID:17585979 |
| clotrimazole | increases expression | ISO | RGD:619574 | 6480464 | Clotrimazole results in increased expression of GFAP protein | CTD | PMID:10223459 |
| clozapine | decreases expression | ISO | RGD:2679 | 6480464 | Clozapine results in decreased expression of GFAP protein | CTD | PMID:18585900 |
| clozapine | increases expression | ISO | RGD:2679 | 6480464 | Clozapine results in increased expression of GFAP mRNA | CTD | PMID:19441803 |
| cocaine | increases expression | ISO | RGD:619574 | 6480464 | Cocaine results in increased expression of GFAP protein | CTD | PMID:15814102 |
| cocaine | decreases expression | ISO | RGD:2679 | 6480464 | Cocaine results in decreased expression of GFAP protein | CTD | PMID:11391778 |
| cocaine | affects expression | ISO | RGD:2679 | 6480464 | Cocaine affects the expression of GFAP protein | CTD | PMID:12670315 |
| cocaine | affects expression | ISO | RGD:2679 | 6480464 | Cocaine affects the expression of GFAP mRNA | CTD | PMID:20187946 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of GFAP protein | CTD | PMID:11882367 |
| coenzyme Q10 | decreases expression | EXP | | 6480464 | coenzyme Q10 results in decreased expression of GFAP mRNA | CTD | PMID:19555370 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of GFAP mRNA | CTD | PMID:19555370 |
| dantrolene | multiple interactions | ISO | RGD:2679 | 6480464 | Dantrolene inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] | CTD | PMID:21879721 |
| dantrolene | multiple interactions | ISO | RGD:2679 | 6480464 | Dantrolene inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] | CTD | PMID:21863293 |
| Delta(9)-tetrahydrocannabinol | decreases expression | EXP | | 6480464 | Tetrahydrocannabinol results in decreased expression of GFAP mRNA | CTD | PMID:21955143 |
| dexamethasone | increases expression | ISO | RGD:619574 | 6480464 | Dexamethasone results in increased expression of GFAP protein | CTD | PMID:22048647 |
| diazinon | affects expression | ISO | RGD:2679 | 6480464 | Diazinon affects the expression of GFAP mRNA | CTD | PMID:17452286 |
| dieldrin | multiple interactions | EXP | | 6480464 | Dieldrin promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] | CTD | PMID:16809432 |
| dimethoate | increases expression | ISO | RGD:2679 | 6480464 | Dimethoate results in increased expression of GFAP mRNA; more ... | CTD | PMID:21941777 |
| disodium selenite | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of GFAP mRNA] | CTD | PMID:17997286 |
| disodium selenite | decreases expression | ISO | RGD:2679 | 6480464 | Sodium Selenite results in decreased expression of GFAP mRNA | CTD | PMID:18209489 |
| elemental selenium | decreases expression | ISO | RGD:619574 | 6480464 | Selenium results in decreased expression of GFAP protein | CTD | PMID:18583539 |
| ethanol | affects expression | ISO | RGD:2679 | 6480464 | Ethanol affects the expression of GFAP protein | CTD | PMID:17262233 |
| ethanol | increases expression | ISO | RGD:2679 | 6480464 | Ethanol results in increased expression of GFAP protein | CTD | PMID:17888892 |
| ethanol | multiple interactions | ISO | RGD:2679 | 6480464 | Calcium deficiency inhibits the reaction [Ethanol results in increased expression of GFAP protein]; more ... | CTD | PMID:17888892 |
| ethanol | increases expression | ISO | RGD:619574 | 6480464 | Ethanol results in increased expression of GFAP protein | CTD | PMID:20621659 |
| ethanol | decreases expression | ISO | RGD:2679 | 6480464 | Ethanol results in decreased expression of GFAP protein; more ... | CTD | PMID:20837132 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of GFAP mRNA | CTD | PMID:21955143 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:2679 | 6480464 | [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] | CTD | PMID:21879721 |
| fluoxetine | increases response to substance | EXP | | 6480464 | GFAP protein results in increased susceptibility to Fluoxetine | CTD | PMID:22113448 |
| fluoxetine | increases expression | EXP | | 6480464 | Fluoxetine results in increased expression of GFAP protein; more ... | CTD | PMID:20857517 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene | CTD | PMID:20938992 |
| gamma-aminobutyric acid | increases expression | ISO | RGD:2679 | 6480464 | gamma-Aminobutyric Acid results in increased expression of GFAP protein | CTD | PMID:17845906 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of GFAP mRNA] | CTD | PMID:17997286 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of GFAP mRNA | CTD | PMID:17997286 |
| isoliquiritigenin | multiple interactions | EXP | | 6480464 | isoliquiritigenin inhibits the reaction [Methamphetamine results in increased expression of GFAP protein] | CTD | PMID:19834288 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of GFAP mRNA; more ... | CTD | PMID:17997037 |
| kainic acid | increases expression | ISO | RGD:2679 | 6480464 | Kainic Acid results in increased expression of GFAP protein | CTD | PMID:22790971 |
| kainic acid | multiple interactions | EXP | | 6480464 | PTGS2 protein inhibits the reaction [Kainic Acid results in increased expression of GFAP mRNA] | CTD | PMID:21589914 |
| kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of GFAP mRNA | CTD | PMID:17997037 PMID:21589914 |
| kainic acid | increases expression | ISO | RGD:2679 | 6480464 | Kainic Acid results in increased expression of GFAP mRNA | CTD | PMID:19700661 |
| ketamine | increases expression | ISO | RGD:2679 | 6480464 | Ketamine results in increased expression of GFAP mRNA | CTD | PMID:20080153 |
| L-ascorbic acid | decreases expression | ISO | RGD:2679 | 6480464 | Ascorbic Acid results in decreased expression of GFAP protein | CTD | PMID:15372504 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GFAP gene | CTD | PMID:20938992 |
| lead diacetate | multiple interactions | ISO | RGD:2679 | 6480464 | [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in decreased expression of GFAP protein | CTD | PMID:20829427 |
| lead diacetate | increases expression | ISO | RGD:2679 | 6480464 | lead acetate results in increased expression of GFAP protein | CTD | PMID:17047031 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of GFAP mRNA | CTD | PMID:21322097 |
| lead diacetate | decreases expression | ISO | RGD:2679 | 6480464 | lead acetate results in decreased expression of GFAP protein | CTD | PMID:20829427 |
| lipoic acid | decreases expression | EXP | | 6480464 | Thioctic Acid results in decreased expression of GFAP mRNA | CTD | PMID:19555370 |
| luteolin | multiple interactions | EXP | | 6480464 | Luteolin inhibits the reaction [Carbon Tetrachloride results in increased expression of GFAP protein] | CTD | PMID:19747501 |
| lycopene | decreases expression | EXP | | 6480464 | lycopene results in decreased expression of GFAP mRNA | CTD | PMID:19555370 |
| manganese atom | decreases expression | ISO | RGD:2679 | 6480464 | Manganese results in decreased expression of GFAP mRNA | CTD | PMID:20224926 |
| manganese atom | increases expression | ISO | RGD:2679 | 6480464 | Manganese results in increased expression of GFAP protein | CTD | PMID:19782702 |
| manganese atom | increases expression | ISO | RGD:2679 | 6480464 | Manganese results in increased expression of GFAP mRNA | CTD | PMID:19782702 PMID:20224926 |
| manganese(0) | decreases expression | ISO | RGD:2679 | 6480464 | Manganese results in decreased expression of GFAP mRNA | CTD | PMID:20224926 |
| manganese(0) | increases expression | ISO | RGD:2679 | 6480464 | Manganese results in increased expression of GFAP protein | CTD | PMID:19782702 |
| manganese(0) | increases expression | ISO | RGD:2679 | 6480464 | Manganese results in increased expression of GFAP mRNA | CTD | PMID:19782702 PMID:20224926 |
| manganese(II) chloride | decreases expression | ISO | RGD:2679 | 6480464 | manganese chloride results in decreased expression of GFAP protein | CTD | PMID:12009774 |
| manganese(II) chloride | increases expression | ISO | RGD:2679 | 6480464 | manganese chloride results in increased expression of GFAP protein | CTD | PMID:12106697 |
| melatonin | multiple interactions | ISO | RGD:2679 | 6480464 | Melatonin inhibits the reaction [Carmustine results in decreased expression of GFAP protein] | CTD | PMID:17572393 |
| methamphetamine | multiple interactions | EXP | | 6480464 | isoliquiritigenin inhibits the reaction [Methamphetamine results in increased expression of GFAP protein] | CTD | PMID:19834288 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:15337264 more ... |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP mRNA | CTD | PMID:21867746 more ... |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:15337264 more ... |
| methamphetamine | increases expression | ISO | RGD:2679 | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:10773198 more ... |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP mRNA | CTD | PMID:12766323 more ... |
| methamphetamine | increases expression | ISO | RGD:2679 | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:9739098 more ... |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:9634552 more ... |
| methamphetamine | increases expression | ISO | RGD:2679 | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:10773198 more ... |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:16088948 more ... |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP mRNA | CTD | PMID:12766323 PMID:9634552 |
| methamphetamine | increases expression | ISO | RGD:2679 | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:9427479 more ... |
| methamphetamine | increases expression | ISO | RGD:2679 | 6480464 | Methamphetamine results in increased expression of GFAP mRNA | CTD | PMID:15644446 |
| methamphetamine | affects expression | ISO | RGD:2679 | 6480464 | Methamphetamine affects the expression of GFAP protein | CTD | PMID:17262233 |
| methamphetamine | multiple interactions | EXP | | 6480464 | SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of GFAP protein]; more ... | CTD | PMID:16088948 |
| methamphetamine | multiple interactions | EXP | | 6480464 | SLC6A3 protein affects the reaction [Methamphetamine results in increased expression of GFAP mRNA]; more ... | CTD | PMID:9634552 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP mRNA | CTD | PMID:9634552 PMID:12766323 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GFAP protein | CTD | PMID:9634552 more ... |
| methimazole | increases expression | ISO | RGD:2679 | 6480464 | Methimazole results in increased expression of GFAP protein | CTD | PMID:22504374 |
| methionine sulfoximine | increases expression | ISO | RGD:2679 | 6480464 | Methionine Sulfoximine results in increased expression of GFAP protein | CTD | PMID:2565645 |
| monocrotaline | affects expression | ISO | RGD:2679 | 6480464 | Monocrotaline affects the expression of GFAP protein | CTD | PMID:21781985 |
| morphine | decreases expression | EXP | | 6480464 | Morphine results in decreased expression of GFAP mRNA | CTD | PMID:21955143 |
| N,N-diethyl-m-toluamide | increases expression | ISO | RGD:2679 | 6480464 | DEET results in increased expression of GFAP protein | CTD | PMID:11681848 |
| N,N-diethyl-m-toluamide | multiple interactions | ISO | RGD:2679 | 6480464 | [DEET co-treated with Permethrin] results in increased expression of GFAP protein | CTD | PMID:11681848 |
| N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of GFAP mRNA | CTD | PMID:15140182 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:2679 | 6480464 | Methylnitrosourea results in increased expression of GFAP protein | CTD | PMID:18155124 |
| N-nitrosodiethylamine | affects expression | ISO | RGD:2679 | 6480464 | Diethylnitrosamine affects the expression of GFAP mRNA | CTD | PMID:20387270 |
| nifedipine | multiple interactions | ISO | RGD:2679 | 6480464 | Nifedipine inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] | CTD | PMID:21863293 |
| nitric oxide | decreases expression | ISO | RGD:2679 | 6480464 | Nitric Oxide deficiency results in decreased expression of GFAP protein | CTD | PMID:15763998 |
| ochratoxin A | multiple interactions | ISO | RGD:2679 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]; more ... | CTD | PMID:15994020 |
| ochratoxin A | decreases expression | ISO | RGD:2679 | 6480464 | ochratoxin A results in decreased expression of GFAP mRNA | CTD | PMID:15994020 |
| paclitaxel | increases expression | ISO | RGD:619574 | 6480464 | Paclitaxel results in increased expression of GFAP protein | CTD | PMID:18098270 |
| paclitaxel | increases expression | ISO | RGD:2679 | 6480464 | Paclitaxel results in increased expression of GFAP protein | CTD | PMID:16854522 PMID:17005179 |
| paclitaxel | multiple interactions | ISO | RGD:619574 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in increased expression of GFAP protein | CTD | PMID:18098270 |
| paclitaxel | increases expression | ISO | RGD:2679 | 6480464 | Paclitaxel results in increased expression of GFAP protein | CTD | PMID:17005179 PMID:16854522 |
| paracetamol | multiple interactions | EXP | | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GFAP mRNA] | CTD | PMID:17585979 |
| paraquat | multiple interactions | EXP | | 6480464 | APOD protein affects the reaction [Paraquat results in increased expression of GFAP protein] | CTD | PMID:21688324 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of GFAP protein | CTD | PMID:21688324 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:2679 | 6480464 | perfluorooctane sulfonic acid results in increased expression of GFAP protein | CTD | PMID:20937303 |
| permethrin | increases expression | EXP | | 6480464 | Permethrin results in increased expression of GFAP protein | CTD | PMID:14555407 |
| permethrin | increases expression | ISO | RGD:2679 | 6480464 | Permethrin results in increased expression of GFAP protein | CTD | PMID:11681848 |
| permethrin | multiple interactions | ISO | RGD:2679 | 6480464 | [DEET co-treated with Permethrin] results in increased expression of GFAP protein | CTD | PMID:11681848 |
| phencyclidine | increases expression | EXP | | 6480464 | Phencyclidine results in increased expression of GFAP mRNA | CTD | PMID:17266109 |
| propionic acid | increases expression | ISO | RGD:2679 | 6480464 | propionic acid results in increased expression of GFAP protein | CTD | PMID:16950524 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [PPT1 gene mutant form results in increased expression of GFAP protein] | CTD | PMID:21224254 |
| resveratrol | multiple interactions | ISO | RGD:2679 | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of GFAP protein] | CTD | PMID:17888892 |
| rosiglitazone | multiple interactions | ISO | RGD:2679 | 6480464 | [rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of GFAP mRNA | CTD | PMID:18543250 |
| rosiglitazone | multiple interactions | ISO | RGD:2679 | 6480464 | rosiglitazone promotes the reaction [Oxidopamine results in increased expression of GFAP protein] | CTD | PMID:22842585 |
| selenium atom | decreases expression | ISO | RGD:619574 | 6480464 | Selenium results in decreased expression of GFAP protein | CTD | PMID:18583539 |
| sodium chloride | decreases expression | ISO | RGD:2679 | 6480464 | Sodium Chloride results in decreased expression of GFAP protein | CTD | PMID:16280599 |
| staurosporine | multiple interactions | ISO | RGD:2679 | 6480464 | Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] | CTD | PMID:21879721 |
| tamibarotene | increases expression | ISO | RGD:2679 | 6480464 | Am 80 results in increased expression of GFAP; more ... | CTD | PMID:19182380 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of GFAP mRNA | CTD | PMID:17555576 |
| tamoxifen | multiple interactions | EXP | | 6480464 | Tamoxifen inhibits the reaction [bisphenol A results in increased expression of GFAP protein] | CTD | PMID:16860915 |
| terbutaline | increases expression | ISO | RGD:2679 | 6480464 | Terbutaline results in increased expression of GFAP protein | CTD | PMID:14610225 |
| tetrachloroethene | decreases expression | ISO | RGD:2679 | 6480464 | Tetrachloroethylene results in decreased expression of GFAP protein | CTD | PMID:8372046 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of GFAP protein | CTD | PMID:19747501 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | Luteolin inhibits the reaction [Carbon Tetrachloride results in increased expression of GFAP protein] | CTD | PMID:19747501 |
| toluene | increases expression | ISO | RGD:2679 | 6480464 | Toluene results in increased expression of GFAP protein | CTD | PMID:10987130 |
| toluene | increases expression | ISO | RGD:2679 | 6480464 | Toluene results in increased expression of GFAP mRNA | CTD | PMID:22166486 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [PPT1 gene mutant form results in increased expression of GFAP protein] | CTD | PMID:21224254 |
| trans-resveratrol | multiple interactions | ISO | RGD:2679 | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of GFAP protein] | CTD | PMID:17888892 |
| valproic acid | decreases expression | ISO | RGD:2679 | 6480464 | Valproic Acid results in decreased expression of GFAP protein | CTD | PMID:18585900 |
| verapamil | multiple interactions | ISO | RGD:2679 | 6480464 | Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] | CTD | PMID:21879721 |
| verapamil | multiple interactions | ISO | RGD:2679 | 6480464 | Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] | CTD | PMID:21863293 |
| zonisamide | multiple interactions | EXP | | 6480464 | zonisamide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] | CTD | PMID:19199078 |